Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 8/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25153643 | 0.78 | POLB (0.35) | — | |
| SCHEMBL17145937 | 0.75 | ALDH1A1 (0.48) | ACHEEPHX1CYP4F2CYP4A11 | |
| SCHEMBL25845438 | 0.74 | MTNR1A (0.38) | — | |
| SCHEMBL21017569 | 0.73 | EPHX1 (0.42) | ACHECNR1EPHX1 | |
| SCHEMBL20243881 | 0.72 | PAOX (0.42) | CNR1EPHX1 | |
| SCHEMBL14153996 | 0.72 | RIPK1 (0.41) | ACHECNR1EPHX1CYP4F2CYP4A11 | |
| SCHEMBL24144844 | 0.71 | CYP4F2 (0.31) | CYP4F2CYP4A11 | |
| SCHEMBL12563356 | 0.71 | ALDH1A1 (0.41) | ACHEEPHX1 | |
| SCHEMBL18856225 | 0.71 | HCAR2 (0.36) | CYP4F2CYP4A11 | |
| SCHEMBL21018352 | 0.70 | EPHX1 (0.49) | CNR1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11633486-B2 | Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease | THE UNIVERSITY OF CHICAGO (US) | 2023-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11633486-B2 | Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease | SI, FABP2, VIP | ACHE 1271/4885CNR1 2936/4885EPHX1 1116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.